For instance, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) have been closely associated with SLE disease activity and the severity of organ involvement, highlighting their potential utility as biomarkers for disease progression [7,8,9]. Here, IL6 is linked to systemic lupus erythematosus.